USPTO serial 90553822
ILLUMINA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 24, 2023
- Examiner
- HISER, CHARLES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ILLUMINA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus and instruments for scientific research in laboratories, namely, genetic sequencers; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Scientific and research apparatus and instruments for use in genetic analysis; Apparatus for DNA and RNA testing for research purposes; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and specifically adapted parts and fittings therefor; Medical laboratory research instruments for DNA and RNA analysis; Apparatus and instruments for testing gas, liquids, and solids; DNA chips; Computer hardware; Data processing apparatus; Computers; Downloadable software for scientific analysis of genetic sequences; Embedded being recorded software for scientific analysis of genetic sequences; Computer hardware for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, scientific research, pharmaceuticals, veterinary research, medicine, diagnostic research, clinical research, drug development, laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, cosmetics, dermatology, metagenomics, genetic testing and genetics; Downloadable software for storing, organizing and creating a searchable library of genetic data for use in sequence detection, and disease detection and diagnosis; Downloadable software for database management and for storage of electronic data; Downloadable software for creating searchable databases of information and data; Downloadable databases in the field of genetics; Scientific and research apparatus and instruments, namely, nucleic acid sequencers, arrays, scanners, electronic imaging devices and analyzers, testing sample collection equipment, sample quality control instruments, sequencing reagent cartridges and trays, and test sample preparation equipment, for laboratory use including in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, medicine, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, cosmetics, dermatology, metagenomics, genetic testing, and genetics; Laboratory trays; Next-generation sequencing (NGS) bioinformatics data processor; Downloadable computer application software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records; Downloadable electronic publications, namely, newsletters and articles in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, cosmetics, dermatology, agrigenomics, genetic testing, and genetics; Downloadable electronic reports in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, and genetics; Downloadable computer software for compressing and decompressing data and files; Downloadable computer software for encrypting data and files; Downloadable computer software for maximizing data and file storage; Downloadable computer programs for use in file compression, file decompression, archiving, and computer file management; Downloadable computer software for accessing and decompressing archives stored in files, and then viewing and downloading one or more decompressed individual files stored inside the original compressed files archive; Downloadable computer software for creating a compressed file archive containing one or more user-selected individual files; Downloadable computer programs and computer software for copying, deleting, comparing, managing, organizing, compressing, decompressing, restoring, repairing, creating, storing, synchronizing, securing and archiving of data and files; Downloadable software for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer chips; Microprocessors; Integrated circuits; Cards with integrated circuits; Encoded electronic chip cards containing programming used for DNA sequencing; next-generation sequencing (ngs) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Downloadable computer software for compressing and decompressing genomic data files | ACTIVE | Jan 9, 2003 |
| 042 | Providing online, non-downloadable computer application software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records; Providing online, non-downloadable computer programs for use in file compression, file decompression, archiving, and computer file management; Providing online, non-downloadable computer programs and computer software for copying, deleting, comparing, managing, organizing, compressing, decompressing, restoring, repairing, creating, storing, synchronizing, securing and archiving of data and files; Providing online, non-downloadable software for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics | ACTIVE | Oct 11, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 21, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 21, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 19, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 1, 2022 | IUAF | USE AMENDMENT FILED | — |
| Dec 1, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 5, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 10, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 10, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 20, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |